• News
  • BioTech

Targeson receives $776,800 in year 2 of SBIR grant

San Diego's Targeson Inc. announced it has received the Notice of Award for year 2 of the company’s 2R44 grant from the National Heart, Lung, and Blood Institute of the National Institutes of Health.

To continue reading, subscribe now
log in to your account
User Response
0 UserComments

Targeson Inc.

Company Website

3550 General Atomics Ct. MS, 02-606
San Diego, CA 92121

Targeson Inc. Executive(s):

Joshua Rychak

  • Co-Founder
Subscribe Today!